Title : Dual Targeting of PI3K and HDAC by CUDC-907 Inhibits Pediatric Neuroblastoma Growth.

Pub. Date : 2022 Feb 20

PMID : 35205815






3 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Our results show that CUDC-907 significantly inhibits NB proliferation and colony growth, induces apoptosis, blocks cell cycle progression, inhibits MYCN, and enhances H3K9Ac levels by inhibiting the PI3K/AKT signaling pathway and HDAC function. CUDC-907 MYCN proto-oncogene, bHLH transcription factor Homo sapiens
2 Our results show that CUDC-907 significantly inhibits NB proliferation and colony growth, induces apoptosis, blocks cell cycle progression, inhibits MYCN, and enhances H3K9Ac levels by inhibiting the PI3K/AKT signaling pathway and HDAC function. CUDC-907 AKT serine/threonine kinase 1 Homo sapiens
3 Overall, our findings highlight that the dual inhibition of PI3K and HDAC by CUDC-907 is an effective therapeutic strategy for NB and other MYC-dependent cancers. CUDC-907 MYC proto-oncogene, bHLH transcription factor Homo sapiens